Public-private partnerships (PPPs)

Public-private partnerships are seen as an effective way to capitalize on the relative strengths of the public and private sectors to address problems that neither could tackle adequately on its own, in particular in respect of diseases that particularly affect developing countries where research by the private sector is deemed insufficient. Thus the public sector contributes both basic science and funding, and the private sector has strengths in drug discovery and bringing candidate drugs through the trials process to regulatory approval. The lack of incentive is addressed by creating a PPP entity with a well-defined objective relating to the development of a particular product or technology required by developing countries.
Documents
-
Combatting Diseases Associated with Poverty: Financing Strategies for Product Development and the Potential Role of Public-Private Partnerships | By Roy Widdus (IPPPH), Katherien White (Consultant, UK) | Initiative on Public-Private Partnerships for Health | April 2004
pdf, 628kb -
Governing Public-Private Infectious Disease Partnerships | By K. Buse Brown | Journal of World Affairs. Winter/Spring 2004 X(2): 225-244
-
Virtual Drug Discovery and Development for Neglected Diseases through Public Private Partnerships | By S. Nwaka and R. Ridley | Nature Reviews, Drug Discovery, Volume 2 | November 2003
-
Public-Private Partnerships for Public Health | edited by Michael R. Reich, Harvard School of Public Health | 2002
-
Public-Private Health Partnerships: A strategy for WHO | By K. Buse and A. Waxman | Bulletin of the World Health Organisation 2001; 79(8): 748-754
-
CMH Working Paper Series, Paper No.WG2:21- Public private partnerships | By Hannah Kettler and Adrian Towse | July 2001
-
Public–private partnerships for health: their main targets, their diversity, and their future directions| By Roy Widdus | WHO, 2001
-
Global public-private health partnerships: Part II – what are the issues for global governance? | By K. Buse and G Walt | Bulletin of the World Health Organisation. 2000; 78 (5): 699-709
-
The global drug gap | By M.R Reich | Science, 287:1979-1981 | 2000
- Product Development Public Private Partnerships for Diseases of Poverty [pdf 1.3mb]